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The Airway Microbiome at Birth
Charitharth Vivek Lal1,2,3, Colm Travers1, Zubair H. Aghai4, Peter Eipers5, Tamas Jilling1,2, 
Brian Halloran1,2, Waldemar A. Carlo1, Jordan Keeley1, Gabriel Rezonzew1, Ranjit Kumar6, 
Casey Morrow5, Vineet Bhandari7 & Namasivayam Ambalavanan1,2,6
Alterations of pulmonary microbiome have been recognized in multiple respiratory disorders. It is 
critically important to ascertain if an airway microbiome exists at birth and if so, whether it is associated 
with subsequent lung disease. We found an established diverse and similar airway microbiome at 
birth in both preterm and term infants, which was more diverse and different from that of older 
preterm infants with established chronic lung disease (bronchopulmonary dysplasia). Consistent 
temporal dysbiotic changes in the airway microbiome were seen from birth to the development of 
bronchopulmonary dysplasia in extremely preterm infants. Genus Lactobacillus was decreased at birth 
in infants with chorioamnionitis and in preterm infants who subsequently went on to develop lung 
disease. Our results, taken together with previous literature indicating a placental and amniotic fluid 
microbiome, suggest fetal acquisition of an airway microbiome. We speculate that the early airway 
microbiome may prime the developing pulmonary immune system, and dysbiosis in its development 
may set the stage for subsequent lung disease.
Microbiome analysis based on sequencing of 16S ribosomal RNA genes characterizes bacterial species present 
both in terms of their identities and relative abundance in contrast to traditional microbiological approaches 
that are restricted to analyzing species that are readily cultured1,2. The study of the human lung microbiome in 
the context of pulmonary health and disease is an area of emerging research3 but it is unknown as to when the 
respiratory microbiome is established, and whether the airways harbor a microbiome soon after birth. Evidence 
of pathogenic roles for specific alterations in airway microbiota is strongest in lung diseases such as cystic fibrosis, 
chronic obstructive pulmonary disease (COPD), and asthma but it is not clear how the airway microbiome is 
initially established in newborn infants3,4. Extremely premature infants are born with developmentally immature 
lungs that are susceptible to multiple injuries, which interfere with pulmonary alveolar and vascular development 
leading to bronchopulmonary dysplasia (BPD). It has been speculated that development of BPD is mediated 
at least in part by inflammation secondary to airway infections, and multiple studies have shown associations 
between lung inflammatory markers and BPD pathogenesis5–8. Yet the direction of causality between airway 
injury during development and respiratory colonization with microorganisms remains unsettled. Should a dis-
ordered airway microbiome prove to be involved in the pathogenesis of disease, it will be of immediate interest 
to attempt to develop novel therapeutic interventions. We hypothesized that an airway microbiome is present at 
birth, and that the airway microbiota at birth would differ between extremely low birth weight (ELBW) preterm 
infants (< 1000 g birth weight) and full term (FT) infants, and would change over time in preterm infants who go 
on to develop BPD. We also hypothesized that early (at birth) airway microbiota would differ in ELBW infants 
who later go on to develop BPD from the ones who are resilient to the disease. We conducted the study initially 
at the University of Alabama at Birmingham (UAB) Regional Neonatal Intensive Care Unit (RNICU) and then 
confirmed our findings using a validation cohort from a different center in Philadelphia. In this study, we found 
a diverse airway microbiome at birth with prognostic potential that becomes dysregulated during development 
of BPD.
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Results
The demographics and clinical characteristics of enrolled patients in the Discovery Cohort are shown in Table 1. 
Based on their pulmonary outcomes, the 23 ELBW infants were further categorized as the ones who did not 
develop BPD (BPD Resistant, n = 13) or the ones who later developed BPD (BPD Predisposed, n = 10) at 36 
weeks’ postmenstrual age (PMA). The demographics and clinical characteristics of enrolled ELBW patients from 
UAB are shown in Table 2.
The validation cohort was also categorized based on their pulmonary outcomes, into infants who did not 
go on to develop BPD (BPD Resistant, n = 7) or the ones who later developed BPD (BPD Predisposed, n = 7). 
The demographics and clinical characteristics of enrolled ELBW patients for the validation cohort are shown in 
Table 3.
To determine the temporal changes in airway microbiome, we collected serial tracheal aspirates (TA) at vari-
ous time points from birth until the development of BPD in 5 infants from the discovery cohort.
The airways of ELBW and FT infants have a distinct microbiota even at birth. We were able to detect 
and characterize bacterial DNA in tracheal aspirates of all ELBW and FT infants soon after birth (Figs 1A and 2). 
All specimens resulted in amplification of the 16S rRNA used for microbiome analysis. Most mothers of premature 
infants received antimicrobial therapy before delivery (Table 4). On statistical analysis, there were no differences in the 
airway microbiome of the infants of mothers who received prenatal antibiotics versus infants of mothers who did not.
Airway microbiome of ELBW and FT infants is similar at birth. The taxonomic analysis in this study 
demonstrated that the lung microbiome was similar at birth in ELBW and FT infants irrespective of gestational 
age (Fig. 1A,C). Both ELBW and FT infants had a predominance of Firmicutes and Proteobacteria on the first day 
of life, in addition to the presence of Actinobacteria, Bacteroidetes, Tenericutes, Fusobacterium, Cyanobacteria, and 
Verrucomicrobia (Fig. 1A). The relative abundance of bacterial phyla did not differ between ELBW and FT infants. 
We compared the diversity between the groups and calculated the Shannon diversity index for alpha diversity 
(which gives an estimate of richness, evenness, and microbial diversity within a sample). There was no difference 
between the Shannon alpha diversity for ELBW and FT infants (p = 0.46, t-test, Fig. 1D). As shown in the principal 
coordinate analysis (PCoA) plot (Fig. 1C), the BPD infant microbiomes clustered separately with a greater Unifrac 
Full term infants, sampled 
on day 1 after birth (FT)
ELBW infants, sampled on 
day 1 after birth (ELBW)
Infants with established 
bronchopulmonary dysplasia (BPD)
Study population, n 10 23 18
Postmenstrual age tracheal aspirate, 
weeks ± SD 38.3 ± 2.2 24.5 ± 0.2 37.6 ± 1.5
Gestational age, weeks ± SD 38.2 ± 2.2 24.3 ± 1.5 25.3 ± 2.1
Birth weight, grams ± SD 3334 ± 521 645 ± 163 731 ± 287
Male sex, no. (%) 8 (80) 8 (35) 9 (50)
Race
 Black, no. (%) 5 (50) 17 (74) 12 (67)
 White, no. (%) 5 (50) 6 (26) 6 (33)
Antenatal corticosteroids, no. (%) 1 (10) 22 (96) 16 (89)
Chorioamnionitis, no. (%) 2 (20) 10 (43) 9 (50)
Rupture of membranes > 18 hours, no. (%) 3 (30) 4 (17) 5 (28)
Cesarean section, no. (%) 4 (40) 15 (65) 12 (67)
Pre-eclampsia, no. (%) 1 (10) 13 (57) 5 (28)
Intrauterine growth restriction, no. (%) 0 (0) 10 (43) 6 (33)
Intubation in delivery room, no. (%) 3 (30) 10 (43) 12 (67)
Respiratory distress syndrome, no. (%) 2 (20) 22 (96) 18 (100)
Treatment with surfactant, no. (%) 2 (20) 21 (91) 18 (100)
High frequency ventilation, no. (%) 1 (10) 7 (26) 7 (39)
Ventilator days, mean ± SD 6 ± 7 32 ± 38 77 ± 49
CPAP days, mean ± SD 1 ± 2 21 ± 19 54 ± 38
Oxygen days, mean ± SD 9 ± 11 92 ± 58 225 ± 92
Died, no. (%) 0 (0) 1 (4) 7 (39)
Bronchopulmonary dysplasia, no. (%) 0 (0) 10 (43) 18 (100)
Pulmonary hemorrhage, no. (%) 0 (0) 5 (22) 2 (11)
Symptomatic patent ductus arteriosus, no. (%) 0 (0) 9 (39) 9 (50)
Sepsis, no. (%) 0 (0) 8 (35) 13 (72)
Intracranial hemorrhage ≥ grade 3, no. (%) 0 (0) 2 (9) 1 (6)
Retinopathy of prematurity ≥ stage 3, no. (%) 0 (0) 2 (9) 4 (22)
Necrotizing enterocolitis ≥ stage 2, no. (%) 0 (0) 5 (22) 4 (22)
Table 1.  Demographic characteristics of ELBW, FT and BPD infants.
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distance separating them, whereas ELBW and FT microbiomes had significant overlap on the PCoA plot (p = 0.19, 
permanova test, Fig. 1C). Tenericutes including genus Ureaplasma were identified in the tracheal aspirates of both 
ELBW and FT infants (Figs 1A and 2), although its relative abundance was higher in ELBW infants.
The microbial composition of the airway is different and less diverse in infants with BPD com-
pared to FT and ELBW infants. Compared to newborn FT infants matched for post-menstrual age, the 
airway microbiome of infants after diagnosis of BPD was characterized by increased phylum Proteobacteria and 
decreased phyla Firmicutes and Fusobacteria (Fig. 1A,B). Gamma Proteobacteria were more abundant in BPD infants 
whereas Alpha Proteobacteria were in lower abundance in BPD infants compared to newborn ELBW and FT infants 
(Fig. 2). At the genus level, the most abundant Proteobacteria in BPD patients were Enterobacteriaceae (Fig. 2).
Differences in microbial composition between BPD and FT infants were confirmed by a difference in Shannon 
alpha diversity (p < 0.002; t-test; Fig. 1D). We used Unifrac-weighted distances for beta diversity (that are inclu-
sive of abundance, the presence or absence of OTUs between samples, and demonstrates how different microbes 
are distributed among samples). We found different clustering as depicted in PCoA plots of Unifrac distances 
(p < 0.0001; permanova test; Fig. 1C). Differences in microbe diversity and abundance (alpha diversity p < 0.003, 
t-test, Fig. 1D; beta diversity p < 0.009, permanova test, Fig. 1C) were seen also between ELBW infants and infants 
with BPD (Figs 1 and 2).
To confirm the presence of Proteobacteria in the BPD patient samples, we also performed specific endotoxin 
assays, the results of which are given below.
Discovery cohort
BPD - Resistant BPD - Predisposed
Study population, n 13 10
Gestational age, weeks ± SD 24.8 ± 1.7 23.5 ± 0.7
Birth weight, grams ± SD * 686 ± 140 564 ± 93
Male sex, no. (%) 4 (31) 4 (40)
Race
 Black, no. (%) 10 (77) 7 (70)
 White, no. (%) 3 (23) 3 (30)
Antenatal corticosteroids, no. (%) 12 (92) 10 (100)
Chorioamnionitis, no. (%) 6 (46) 4 (40)
Rupture of membranes > 18 hours, no. (%) 3 (23) 1 (10)
Cesarean section, no. (%) 8 (62) 7 (70)
Pre-eclampsia, no. (%) 7 (54) 6 (60)
Intrauterine growth restriction, no. (%) 4 (31) 6 (60)
Intubation in delivery room, no. (%) 5 (38) 5 (50)
Respiratory distress syndrome, no. (%) 12 (92) 10 (100)
Treatment with surfactant, no. (%) 11 (85) 10 (100)
High frequency ventilation, no. (%) 2 (15) 5 (50)
Ventilator days, mean ± SD * 13 ± 18 58 ± 43
CPAP days, mean ± SD 14 ± 14 29 ± 23
Oxygen days, mean ± SD * 51 ± 39 145 ± 26
Died, no. (%) 0 (0) 0 (0)
Pulmonary hemorrhage, no. (%) 2 (15) 3 (30)
Symptomatic patent ductus arteriosus, no. (%) 6 (46) 3 (30)
Sepsis, no. (%) 4 (31) 4 (40)
Intracranial hemorrhage ≥ grade 3, no. (%) 2 (15) 0 (0)
Retinopathy of prematurity ≥ stage 3, no. (%) 0 (0) 2 (20)
Necrotizing enterocolitis ≥ stage 2, no. (%) 1 (8) 4 (40)
Table 2.  Discovery Cohort – Demographics.
Validation cohort
(BPD - Resistant) (BPD - Predisposed)
Study population, n 7 7
Gestational age, weeks ± SD 25.1 ± 0.7 24.8 ± 1.7
Birth weight, grams ± SD 700 ± 340 686 ± 140
Male sex, no. (%) 5 (71) 4 (57)
Table 3.  Validation Cohort – Demographics.
www.nature.com/scientificreports/
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Airway microbiome of ELBW infants who go on to develop BPD show a consistent temporal dysbiosis. 
Five extremely premature infants were followed from birth until the development of BPD and serial TA collected 
at various postnatal time points (Day 1–7, Day 8–21, Day 21–40, Day 41–60, Day > 60) (Fig. 3). The first sample 
(labeled day 1–7) was collected on day 1 in 4 of the 5 patients (Patient A, B, C, D), whereas in the 5th patient the 
first sample was collected on day 5. The demographics of these infants are given in Table 5. All 5 infants, despite 
having multiple courses of antibiotics at various different time points, had a distinct temporal dysbiotic change 
with a decrease in Firmicutes and increase in abundance of Proteobacteria over time (Fig. 3).
ELBW infants born by cesarean section (CS) and vaginal delivery have airway microbiota that 
do not differ at birth. Of the 23 ELBW infants in the discovery cohort, 15 (65%) were born by CS and 8 
(35%) by vaginal delivery. There were no statistical differences between the airway microbiota of ELBW infants 
born by CS compared to the ones born by vaginal delivery (all microbial taxa: p > 0.1, t-test).
Genus Lactobacillus was decreased in airway microbiota of ELBW infants with chorioamnionitis. 
Among our discovery cohort of 23 ELBW infants, 10 (43%) had histological chorioamnionitis. The microbiome 
of infants with versus without histological chorioamnionitis differed at the genus level but not at the phylum level. 
A decreased abundance of genus Lactobacillus was seen in infants exposed to chorioamnionitis as compared to 
infants not exposed to chorioamnionitis (p = 0.037, t-test, Fig. 3D). Among our validation cohort of 14 infants, 
only 2 had chorioamnionitis and hence this analysis was not possible (Table 3).
Figure 1. Comparison of lung microbiota of newborn infants and patients with BPD. (A) Bar graph 
depicting the relative abundance of most commonly encountered bacterial phyla between FT, ELBW and BPD 
infants. (B) Compared to newborn postmenstrual age matched FT infants and ELBW infants, infants with BPD 
have increased Proteobacteria and decreased Firmicutes and Fusobacteria. (C) Principal coordinates analysis 
‘PCoA’ plot (beta diversity) demonstrating unweighted UniFrac distance between samples with sample points 
colored for ELBW, FT or BPD infants. Samples that are clustered closely together are considered to share a larger 
proportion of the phylogenetic tree in comparison to samples that are more separated. ELBW and FT infants 
have similar beta diversity, which is very different from the beta diversity of BPD infants. (D) Shannon diversity 
index depicting less microbial alpha diversity in infants with BPD compared to FT and ELBW infants.
www.nature.com/scientificreports/
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Genus Lactobacillus is less abundant in the early airway microbiome of infants who later 
develop BPD. ELBW infants from both our discovery cohort and validation cohort were subdivided into 
two groups based on their pulmonary outcomes into either BPD Resistant or BPD Predisposed.
Discovery Cohort. All 23 ELBW infants survived to 36 weeks PMA and were similar in demographic charac-
teristics (Table 2). 10 of these 23 infants went on to develop BPD (BPD Predisposed) (Fig. 4). 13 of the 23 ELBW 
did not develop BPD and were deemed resistant to the disease (BPD Resistant) (Fig. 4). The relative phylum level 
microbial abundance (Fig. 4A,B) and alpha diversity (p = 0.18, Fig. 4C) were not statistically different between the 
BPD Resistant and BPD Predisposed groups. However at the genus level, genus Lactobacillus was less abundant in 
BPD Predisposed infants at birth, compared to the BPD Resistant infants (p < 0.05, t-test; Fig. 4A).
Validation Cohort. ELBW infants from our validation cohort were similarly subdivided into two groups 
based on their pulmonary outcomes – BPD Resistant (7 infants) and BPD Predisposed (7 infants). Both groups 
were similar in demographic characteristics (Table 3). Consistent with the findings of our discovery cohort, 
Lactobacillus was less abundant at the genus level in BPD Predisposed infants at birth compared to the BPD 
Resistant (p < 0.04, t-test; Fig. 5A). The relative phylum level microbial abundance (Fig. 5A,B) and diversity 
(p > 0.1, Fig. 5C) were not statistically different between the BPD Resistant or BPD Predisposed groups.
Figure 6 demonstrates the relative difference in Lactobacillus, in both discovery and validation cohorts.
Endotoxin levels are increased in airways of infants with established BPD. Using a highly specific 
limulus amebocyte lysate (LAL) endotoxin assay we determined endotoxin (proteobacterial products) concentra-
tions in TA. Endotoxin expression was significant increased in infants with established BPD compared to infants 
at birth (Fig. 7A, p < 0.05). This corresponds to our airway microbiome analysis finding of increased proteobacte-
ria in infants with established BPD, compared to ELBW or FT infants at birth. At birth, endotoxin concentrations 
in airways of BPD Resistant and BPD Predisposed ELBW infants showed a statistically non-significant trend 
towards increase in BPD Predisposed infants, (Fig. 7B, p = 0.1). In addition, no difference was seen in endotoxin 
levels in ELBW infants versus FT infants at birth (p > 0.1, data not shown).
Discussion
In this study, we evaluated the airway microbiome of extremely preterm and term infants soon after birth and in 
preterm infants with established BPD. A major novel finding was that the airways have a diverse microbiome even 
at birth regardless of gestational age. To date, it has been considered that infant mucosal surfaces are populated by 
skin, vaginal, and intestinal microbes derived from the mother9. As it is commonly believed that colonization of 
Figure 2. Genus level lung microbial abundance of ELBW infants, FT infants and patients with BPD. 
Heatmap depicting the relative abundance of the most common bacterial families at the genus level. Statistically 
significant difference in microbial abundance is seen between lung microbiome of ELBW and BPD infants (* ) 
and between FT and BPD infants (#).
www.nature.com/scientificreports/
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neonates originates in the birth canal, we were surprised to find that the airway microbiome of vaginally delivered 
and caesarean section-delivered neonates were similar, which suggests that the microbial DNA in the airways 
is probably transplacentally derived, consistent with reports that the placenta has a rich microbiome10. We also 
found that airway microbiota in infants with BPD has decreased diversity and is very different from that of either 
preterm infants soon after birth, or full term infants at a similar post-menstrual age. Our observations indicate 
that the early airway microbiota is associated with the development of BPD in ELBW infants and the airway 
microbiome shows consistent changes over time from birth to the development of BPD.
In the absence of direct access to the newborn lung tissue and due to the inability to obtain broncheoalveolar 
lavage fluid in newborn infants, tracheal aspirates are a surrogate for evaluation of the processes in the lower 
airways and distal lungs. To date, two studies have utilized culture independent methods to detect airway organ-
isms in preterm infants. In a study of 10 infants, Mourani et al.11 demonstrated that airways of premature infants 
are not sterile. In their study, Staphylococcus, Ureaplasma parvum, and Ureaplasma urealyticum were the most 
frequently identified dominant organisms, among other identified organisms like Pseudomonas, Enterococcus, 
and Escherichia. Lohmann et al.12 studied the respiratory microbiome of 25 preterm infants but did not eval-
uate the microbiota of normal term infants. Our study provides a more detailed comparison of the respiratory 
microbiome of ELBW, FT and BPD infants. The tight gestational age criteria in our ELBW group (mean gestation 
of 24.3 ± 1.5 weeks) helped us study the infants who are at the highest risk of developing BPD. In our cohort, 
most mothersof ELBW infants received prenatal antimicrobial therapy close to delivery. As it is routine clinical 
practice to treat mothers in preterm labor with antimicrobials, it is difficult to generate an adequate sample size 
to determine the effect of antimicrobial therapy on the neonatal airway microbiome as there are very few infants 
who are not exposed.
A strength of our study was the sterile collection of tracheal aspirate samples from intubated ELBW and FT 
infants at or within six hours of birth, thus reducing the chances of contamination or postnatal colonization. Only 
samples with > 1000 sequence reads were utilized for the qualitative analysis, thus further reducing the chances 
of erroneous results. Samples with low bacterial biomass were discarded. The increase in Proteobacteria in infants 
established BPD was marked by a corresponding increase in endotoxin levels, which adds validity to our micro-
biome analysis.
In this study we employed genomic approaches rather than culture, and utilized separate development and 
validation cohorts to explore the predictive role of airway microbiome at birth for the future development of BPD. 
Patient
Maternal Antibiotics 
(within 72 hrs prior to birth) Type of Antibiotics
BPD Predisposed
 1 No
 2 Yes ampicillin, amoxicillin, gentamicin
 3 No
 4 No
 5 Yes cefazolin
 6 Yes ampicillin
 7 Yes amphotericin B
 8 Yes acyclovir
 9 Yes ampicillin, gentamicin
 10 Yes cefazolin
BPD Resistant
 1 Yes ampicillin
 2 Yes amphotericin B, azithromycin, clindamycin, gentamicin
 3 Yes cefazolin
 4 No
 5 Yes ampicillin, amoxicillin, azithromycin
 6 Yes ampicillin
 7 Yes ampicillin, amoxicillin, azithromycin
 8 Yes ampicillin
 9 Yes ampicillin
 10 Yes ampicillin
 11 Yes ampicillin, cefepime, vancomycin, acyclovir
 12 No
 13 Yes acyclovir
Table 4.  Maternal antibiotic administration prior to birth in ELBW infants.
www.nature.com/scientificreports/
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A central finding was the decreased Lactobacillus abundance in airway microbiome of infants born to mothers 
with chorioamnionitis. Gritz and Bhandari13 have recently highlighted the importance of Lactobacillus spp. in 
Figure 3. Temporal changes in airway microbiome of ELBW infants who develop BPD. Pie charts showing 
the changes in airway microbiome with time in 5 ELBW patients (A–E) from birth onwards. In all patients, 
a relative increase in abundance of Proteobacteria and a relative decrease in abundances of Firmicutes, 
Actinobacteria, Tenericutes, Bacteroidetes and other microbes, are seen with time.
Patient A B C D E
Gestational age, weeks 23 23 23 22 24
Birth weight, grams 510 660 640 460 520
Sex Female Male Male Female Female
Race Caucasian African American Caucasian Caucasian African American
Antenatal corticosteroids Y Y Y N Y
Chorioamnionitis N Y Y Y Y
Rupture of membranes > 18 hours N Y N N Y
Pre-eclampsia N N N N N
Intrauterine growth restriction Y N N N N
Apgar - 1 minute 5 3 2 — 1
Apgar - 5 minutes 8 8 2 — 3
Intubation in delivery room Y N Y Y Y
Respiratory distress syndrome Y Y Y Y Y
Treatment with surfactant Y Y Y Y Y
High frequency ventilation N N N Y Y
Pulmonary hemorrhage N N N N Y
Symptomatic patent ductus arteriosus Y N Y N N
Sepsis Y Y N N N
Intracranial hemorrhage ≥ grade 3 N N N Y N
Retinopathy of prematurity ≥ stage 3 Y N N N N
Necrotizing enterocolitis ≥ stage 2 Y N N N N
Table 5.  Demographic characteristics of 5 ELBW infants who later develop BPD.
www.nature.com/scientificreports/
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preterm infants. Also, as chorioamnionitis is an independently associated risk factor for BPD14, this finding could 
be important in defining the association of chorioamnionitis and BPD. We also found decreased Lactobacillus 
abundance at birth in the airways of BPD-Predisposed ELBW infants as compared to BPD-Resistant infants. 
This finding is congruent with findings of Lynch et al.15–17, who have reported a beneficial role of lactobacil-
lus in other airway diseases. Studies in mice have shown that intranasal administration of lactobacilli may 
be more potent than intragastric application in reducing allergic airway inflammation, possibly linked to an 
increase in T-regulatory cells in the lungs18. Other investigators have shown that higher bacterial abundance 
in non-specific-pathogen-free mice correlated with more and smaller size alveoli indicating better lung devel-
opment, which was corroborated by transplanting Lactobacillus spp. into germ-free mice, which responded by 
improvement in alveolar development19. We have recently shown that fecal microbiota in preterm infants may 
vary by center20, and it is possible that there is center variation in airway microbiota as well, which may lead to 
center variation in short-term as well as longer-term pulmonary outcomes. Hence, we validated our findings with 
patient samples from a different center. Relative decreased Lactobacillus abundance at birth in airway microbi-
ome was found to be predictive of BPD in the validation cohort as well. Our results indicate that the respiratory 
microbiome at birth could potentially be used for prognosis, and may potentially be modulated perhaps using 
“respiratory probiotics” for therapeutic interventions in preterm lung disease. Although it is known that mode 
of delivery can shape the acquisition and structure of the skin microbiota in newborns9, our study found no 
differences between the respiratory microbiome of ELBW infants born by cesarean section versus those born by 
vaginal delivery. This finding indicates that the airway microbiome is probably established well before delivery (as 
it is diverse and similar in both extremely preterm and term infants), and is potentially through a transplacental 
passage of bacterial products. Aagard et al.10 have shown that the placental microbiome is very diverse, resembles 
the oral microbiome, and is similar to the airway microbiome in this study. Stout et al.21 have also demonstrated 
gram positive and negative intracellular bacteria in the basal plates of 27% of all placentas, even though it is highly 
Figure 4. Early airway microbiome of ELBW infants and its association with development of BPD – 
Discovery Cohort. (A) Heat map showing the relative abundance of genera across day 1 samples from ELBW 
infants who go on to develop BPD (BPD - Predisposed) versus those who do not (BPD Resistant). Abundance 
of genus Lactobacillus (###) is reduced in BPD - Predisposed group (p = 0.05). (B) Phylum level distribution of 
lung microbiome shows no major differences between groups. (C) Shannon diversity index alpha diversity is not 
statistically different between groups (p = 0.18). (D) Bar graph depicting lower abundance of genus lactobacillus 
in infants born to mothers with chorioamnionitis.
www.nature.com/scientificreports/
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Figure 5. Early airway microbiome of ELBW infants and its association with development of BPD – 
Validation Cohort. (A) Heat map showing the relative abundance of genera across day 1 samples from ELBW 
infants who go on to develop BPD (BPD Predisposed) versus those who do not (BPD Resistant). Abundance of 
genus Lactobacillus (* * * ) is reduced in BPD Predisposed group (p = 0.04). (B) Phylum level distribution of lung 
microbiome shows no major differences between groups. (C) Shannon diversity index shows no difference in 
alpha diversity between groups (p > 0.1).
Figure 6. Early airway Lactobacillus abundance in discovery and validation cohorts. Bar graphs depicting 
the relative abundance of Lactobacillus in ELBW infants at birth. In both the discovery cohort and the validation 
cohort the relative abundance of Lactobacillus is significantly higher in the BPD Resistant infants compared to 
BPD Predisposed infants (p < 0.05).
www.nature.com/scientificreports/
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probable that visual identification in a few selected high power fields is likely to be a marked underestimate. We 
speculate that the biologic rationale for why the placental microbiome resembles the oral microbiome10 and the 
neonatal airway microbiome is because a hematogenous transfer of oral microbes to the placenta10,22–25 followed 
by transplacental transfer of placental microbiota ensures that the early airway microbiome and its associated 
pathogen-associated molecular patterns can initiate establishment of respiratory innate immunity before res-
piratory pathogens can establish a niche. Alternatively there could be a local microbial transfer from placenta to 
the amniotic fluid, which the fetal lungs acquire. Multiple studies utilizing culture and culture-independent have 
now confirmed that various bacterial species are detected in amniotic fluid26. The amniotic fluid microbiota and 
the airway microbiota could have a common origin from the placenta, and the level of microbial cross-transfer 
between these pools needs to be determined.
Although all attempts were made to collect TA specimens in a sterile fashion, there is a possibility that con-
tamination could have occurred as inhaled microbiota could contribute to the airway microbiome27. This could 
explain the increased Genus Staphylococcus abundance at birth in the airways of BPD - Predisposed ELBW 
infants in our discovery cohort, which was not validated in the samples from our second site. Also, TAs might not 
represent the true microbiome of the distal lungs and could contain oral microbiota or aspirated gastric micro-
biota in addition to airway microbiota. Hence we employed our research strategy of very early (at birth or within 
6 hours) collection of TA samples, when none of the infants were feeding. In addition we used samples with only 
> 1000 sequence reads. A limitation of our study is the absence of “normal” full term controls to compare with 
diseased group, as normal infants do not get intubated. Although our FT infant cohort might not be the perfect 
controls, they were the only and the closest available options. Another limitation is the qualitative nature of our 
study, as we have not performed individual bacterial quantifications.
Serial microbiome analysis from the same patient may yield useful information on temporal changes leading 
to BPD. Hence we collected TA samples from extremely preterm infants in a serial fashion, and found consistent 
temporal changes in the airway microbiome from birth until the development of BPD. These infants were of 
the smallest viable gestational ages from 22–24 weeks, and hence were the most prone to develop BPD. All five 
infants had similar temporal changes in the airway microbiota – that of increasing abundance of Proteobacteria 
and decreased Firmicutes in airway microbiome over time, despite multiple courses of antibiotics at different 
time points. Genus Lactobacillus has been known to have strong anti-inflammatory properties28–33, and has been 
shown to regulate alveolar development in animal models19. Hence, the temporal microbial dysbiosis consisting 
of the increase in Proteobacteria and decrease in Firmicutes such as Lactobacillus may contribute to the airway 
inflammation associated with BPD and resulting impairment in lung development. The serial tracheal sample 
findings in our study do show that the initial lung microbiome in infants tends to evolve over time. It is likely 
that the postnatal changes in the airway microbiome are driven by exposure to environmental microbes, and is 
modulated by antimicrobial therapy to the infant.
Further understanding of the role of the complex airway microbiome in preterm infants requires investigation 
of the interactions among genes of the microbiota and host. There is a possibility that the microbiome may have 
beneficial cross-talk with the host preterm lung and the reduced diversity of microbes resulting from intensive 
care interventions makes the host lung more susceptible for injury and inflammation. The lung microbiome, 
similar that of other compartments, may be manipulated to correct dysbiosis and restore “healthy” microbial 
Figure 7. Limulus amebocyte lysate chromogenic endotoxin levels in tracheal aspirates of infant.  
(A) Endotoxin concentrations are increased in tracheal aspirate samples collected from infants with BPD 
compared to infants at birth (p < 0.05). (B) No difference was seen in endotoxin amounts in airways of BPD 
Resistant and BPD Predisposed ELBW infants at birth (p = 0.1).
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communities via use of probiotics, prebiotics or antibiotics. Early life gut microbial alterations include changes in 
the production of microbial-derived metabolites, and a similar phenomenon may happen in the lungs34. Hence, 
future in-depth studies of the fetal pulmonary microbiome are warranted and are ongoing. In addition, further 
research on the gut–lung axis and the potential role of extra-pulmonary microbes in the development of respira-
tory disease needs to be explored.
Methods
We conducted a prospective observational cohort study between October 2014 and March 2015 at the University 
of Alabama at Birmingham (UAB) Regional Neonatal Intensive Care Unit. The Institutional Review Board of 
University of Alabama at Birmingham approved the human subject protocol and granted waiver of consent sta-
tus as samples were obtained from routine clinical care and were handled in a completely de-identified manner. 
The methods were carried out in accordance with the approved guidelines. Further details are in the online data 
supplement.
Patient population. Discovery Cohort (UAB). Inborn and outborn ELBW and FT infants who underwent 
endotracheal intubation and mechanical ventilation at birth (in the first 6 hours of life) were included. In addition, 
infants diagnosed with moderate or severe BPD at 36 weeks’ PMA defined using the physiologic definition35 were 
included. Samples from a total of 150 infants were collected but only 51 were utilized for analysis presented in this 
manuscript based on strict inclusion criteria (23 ELBW infants and 10 FT infants – samples obtained at birth or 
within 6 hours of birth at the time of intubation; 18 infants with established BPD - samples obtained at 36 weeks 
PMA at the time of ETT change; samples with only > 1000 bacterial sequence reads were used). All 10 full term 
infants enrolled, were intubated at or within 6 hours of birth due to either surgical indications (congenital heart 
disease, abdominal wall defect) or due to perinatal depression (with no signs of meconium aspiration syndrome). 
Sample size calculations could not be performed as no baseline data in this population was available, this being 
the first study of its kind in the field, but statistical power was established using standard statistical methods as 
described later.
No specific exclusions were made. Chorioamnionitis was determined by placental histopathology and all 
mothers with chorioamnionitis were administered antibiotics prenatally.
Validation Cohort (Philadelphia). We utilized patient samples from Philadelphia as a validation cohort to con-
firm our data. TA samples from Inborn and outborn ELBW infants who underwent endotracheal intubation and 
mechanical ventilation at birth were included. These samples were collected as part of ongoing studies36–38.
Sample collection. Tracheal aspirate (TA) specimens were obtained from patients at the time of intubation 
in the first hours of life and thereafter whenever tracheal suctioning was clinically indicated, per unit protocol. 
Samples were obtained after ensuring that the infant was adequately oxygenated. The protocol for TA collection 
involved instillation of 1 mL sterile isotonic saline into the infant’s endotracheal tube, manual bagging through 
the endotracheal tube for three breaths, and suctioning of the fluid into a sterile mucus trap. Samples were stored 
frozen in − 80oC until further processing. A similar protocol was employed at both study sites.
Isolation of microbial DNA, creation of 16S V4 amplicon library and DNA sequencing. Microbial 
genomic DNA was isolated and PCR was used with unique bar coded primers to amplify the V4 region of the 16S 
rRNA gene to create an “amplicon library” from individual samples39,40. The PCR products were sequenced using 
the NextGen sequencing Illumina MiSeq platform39. The sequence data covered the 16S rRNA V4 region with 
a PCR product length of ~255 bases and 250 base paired-end reads. Sequences were grouped into operational 
taxonomic units (OTUs). Only samples with > 1000 reads were included. Alpha diversity value (within sample 
diversity) was calculated using Shannon’s indez41. Difference in alpha diversity amongst samples was calculated 
using t-tests. Unifrac analysis was used to determine relationships between different samples (beta diversity)42. 
Differences in beta diversity among different groups were measured using permanova test. Principal coordinates 
analysis (PCoA) was used visualize the dissimilarity between all the samples. 3D PCoA plots were generated 
using EMPEROR43. All raw data files have been uploaded online on Sequence Read Archive (SRA - SUB1512169).
Clinical data collection. Data collection was performed via electronic medical record review at time of 
enrollment and during remainder of hospitalization. Chorioamnionitis was determined by histopathology, BPD 
at 36 weeks’ post-menstrual age was defined by the physiologic definition35, and late sepsis was defined as a pos-
itive blood culture after 72 h of life.
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